News & Analysis on Clinical Trial Services & Contract Research And Development
Weekly Comment
Vioxx. Bextra. Zyprexa, Seroxat. At no period of time have so many high-profile drugs come under the spotlight as drug companies face legal action over drug safety. It's make or break time for the pharmaceutical industry as drug companies are possibly...
US researchers examining the role of a protein in nerve branch, or dendrite, patterning, have expressed delight to the protein's possibilities as a viable drug target in therapies aimed at learning and memory disorders.
Japanese pharmaceutical company Shionogi has said it plans to sell its capsule subsidiary Shionogi Qualicaps to private investment group the Carlyle Group in order to focus on its drug development activities.
According to a new report, the bioinformatics market is set to surge ahead, boosted by data proliferation and the need for improved drug research productivity. Along with the solid support of national governments, the European bioinformatics industry...
The first pharmaceutical and diagnostic products using a desiccant film developed by packaging company Alcan could be on the market in 2006.
Researchers in the US have discovered a way of generating stem cells that could avoid the use of human embryos, potentially bypassing one of the major obstacles to the development of therapies based on this technology.